Cite
HARVARD Citation
Shibaki, R. et al. (2022). Impact of pre‐existing interstitial lung abnormal shadow on lung injury development and severity in patients of non‐small cell lung cancer treated with osimertinib. Cancer medicine. pp. 3743-3750. [Online].